Your activity: 6 p.v.

Medical therapy for mild to moderate ulcerative colitis

Medical therapy for mild to moderate ulcerative colitis
Role Medication Brand name
(United States or as noted)
Usual dose
Induction of remission Topical (rectal) mesalamine*
Suppository Canasa, Mezera, Pentasa, Salofalk 1 gram (one suppository) once daily at bedtime
Retention enema Pentasa, Rowasa, Salofalk 4 grams once daily at bedtime or twice dailyΔ
Rectal foam (United States: Not available) Mezera 2 grams (two actuations) once daily at bedtime
Topical (rectal) glucocorticoids
Hydrocortisone suppository Anucort-HC, Anusol-HC, Hemmorex-HC, Proctocort One suppository (25 or 30 mg) once or twice daily
Hydrocortisone aerosol foam 10% Cortifoam 90 mg (one applicatorful) once or twice daily
Hydrocortisone enema Cortenema, Colocort 100 mg (one 60 mL unit) once or twice daily
Oral 5-aminosalycylic acid (5-ASA) derivatives
Sulfasalazine tablet Azulfidine, Salazopyrin 4 grams per day in four divided doses
Mesalamine*
  • Delayed release enteric coated tablet
Asacol, Asacol HD 2.4 to 4.8 grams daily in three divided doses
Octasa 4.8 grams daily or in divided doses
Salofalk 3 to 4 grams daily in three to four divided doses
  • Capsule containing delayed release enteric coated tablet
Delzicol 2.4 grams daily in three divided doses
  • Delayed and extended release tablet, multimatrix (MMX)
Lialda, Mezavant 2.4 to 4.8 grams daily once daily
  • Capsule containing delayed release enteric coated granules
Apriso 1.5 to 4.5 grams once each morning
  • Controlled release capsule
Pentasa 4 grams daily in four divided doses
  • Mesalamine granules (United States and Canada: Not available)
Salofalk sachet 1.5 to 3 grams daily in one to three divided doses
Pentasa sachet 2 to 4 grams daily in two to four divided doses
Olsalazine capsule Dipentum 2 to 3 grams daily in two to four divided doses
Balsalazide capsule Colazal 6.75 grams daily in three divided doses
Oral glucocorticoids
Budesonide delayed and extended release tablet, multimatrix (MMX) Uceris 9 mg once daily in the morning for eight weeks
Prednisone or prednisolone   40 to 60 mg once daily in the morning or in two divided doses
Maintenance of remission Topical (rectal) mesalamine*
Suppository Canasa, Mezera, Pentasa, Salofalk 1 gram (one suppository) once daily at bedtime
Enema Pentasa, Rowasa, Salofalk 1 to 4 grams once daily at bedtimeΔ
Oral 5-aminosalycylic acid (5-ASA) derivatives
Sulfasalazine tablet Azulfidine, Salazopyrin 3 to 4 grams daily in three or four divided doses
Mesalamine*
  • Delayed release enteric coated tablet
Asacol, Asacol HD 1.6 to 2.4 grams daily in one to three divided doses
  • Capsule containing delayed release enteric coated tablet
Delzicol 1.6 to 2.4 grams daily in one to three divided doses
  • Delayed and extended release tablet, multimatrix (MMX)
Lialda, Mezavant 2.4 to 3.6 grams once daily
  • Capsule containing delayed release enteric coated granules
Apriso 1.5 to 3 grams once each morning
  • Controlled release capsule
Pentasa 1.5 to 4 grams daily in three to four divided doses
  • Mesalamine granules (United States and Canada: Not available)
Salofalk sachet 1.5 to 4 grams daily in one to three divided doses
Pentasa sachet 2 to 4 grams once daily
Olsalazine capsule Dipentum 1 gram daily in two divided doses
Balsalazide capsule Colazal 2.25 to 6.75 grams daily in three divided doses
Choice of medication is based on factors including disease location, patient preference and tolerance, and medication availability; refer to UpToDate topic. Approved uses vary by drug, formulation, and country. Refer to product-specific labeling for more detail. Generic (nonproprietary) products may also be available.

5-ASA: 5-aminosalicylate.

* Mesalamine is United States generic name. Mesalazine is an international generic (nonproprietary) name.

¶ Not available in the United States; however, is available in other areas (eg, Canada, United Kingdom, Europe).

Δ In the United States, mesalamine enema is available as 4 g/60 mL. Other concentrations and dosages are available elsewhere. Refer to product-specific information.

◊ Oral mesalamine may be dosed once daily instead of multiple times daily; there is no significant difference in efficacy and safety.[1,2]
Data courtesy of authors with additional data from:
  1. Ko CW, Singh S, Feuerstein JD, et al. American Gastroenterological Association Institute Clinical Guidelines Committee. AGA clinical practice guidelines on the management of mild-to-moderate ulcerative colitis. Gastroenterology 2019; 156:748.
  2. Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: Ulcerative colitis in adults. Am J Gastroenterol 2019; 114:384.
  3. Lexicomp Online. Copyright © 1978-2023 Lexicomp, Inc. All Rights Reserved.
Graphic 86774 Version 14.0